Review
doi: 10.1038/nrc1188.
Cannabinoids: potential anticancer agents
Affiliations
- PMID: 14570037
- DOI: 10.1038/nrc1188
Item in Clipboard
Review
Cannabinoids: potential anticancer agents
Nat Rev Cancer.
2003 Oct.
Abstract
Cannabinoids - the active components of Cannabis sativa and their derivatives - exert palliative effects in cancer patients by preventing nausea, vomiting and pain and by stimulating appetite. In addition, these compounds have been shown to inhibit the growth of tumour cells in culture and animal models by modulating key cell-signalling pathways. Cannabinoids are usually well tolerated, and do not produce the generalized toxic effects of conventional chemotherapies. So, could cannabinoids be used to develop new anticancer therapies?
Similar articles
-
Cannabinoids and cancer: potential for colorectal cancer therapy.Biochem Soc Trans. 2005 Aug;33(Pt 4):712-4. doi: 10.1042/BST0330712. Biochem Soc Trans. 2005. PMID: 16042581 Review.
-
[Different views on the association between cannabinoids and cancer].Cas Lek Cesk. 2006;145(6):453-7; discussion 458-9. Cas Lek Cesk. 2006. PMID: 16835997 Review. Slovak.
-
[Therapeutic applications and biomedical effects of cannabinoids; pharmacological starting points].Ned Tijdschr Geneeskd. 1997 Aug 30;141(35):1689-93. Ned Tijdschr Geneeskd. 1997. PMID: 9543785 Review. Dutch.
-
Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.J Support Oncol. 2007 May;5(5 Suppl 3):1-9. J Support Oncol. 2007. PMID: 17566383 Review.
-
Cannabinoids:their role in pain and palliation.J Pain Palliat Care Pharmacother. 2007;21(3):19-28. J Pain Palliat Care Pharmacother. 2007. PMID: 18032352 Review.
Cited by
-
A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumors.Neurooncol Pract. 2020 Jul;7(4):376-383. doi: 10.1093/nop/npaa013. Epub 2020 Apr 3. Neurooncol Pract. 2020. PMID: 32765889 Free PMC article. Review.
-
Cannabinoids in cancer treatment: Therapeutic potential and legislation.Bosn J Basic Med Sci. 2019 Feb 12;19(1):14-23. doi: 10.17305/bjbms.2018.3532. Bosn J Basic Med Sci. 2019. PMID: 30172249 Free PMC article. Review.
-
Targeted molecular therapy of malignant gliomas.Curr Neurol Neurosci Rep. 2005 May;5(3):186-97. doi: 10.1007/s11910-005-0046-8. Curr Neurol Neurosci Rep. 2005. PMID: 15865884 Review.
-
Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator.Br J Pharmacol. 2010 Aug;160(7):1583-94. doi: 10.1111/j.1476-5381.2010.00841.x. Br J Pharmacol. 2010. PMID: 20649563 Free PMC article.
-
Effect of the Cannabinoid Agonist WIN 55,212-2 on Neuropathic and Visceral Pain Induced by a Non-Diarrheagenic Dose of the Antitumoral Drug 5-Fluorouracil in the Rat.Int J Mol Sci. 2023 Sep 22;24(19):14430. doi: 10.3390/ijms241914430. Int J Mol Sci. 2023. PMID: 37833878 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
